TMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now. TMP just posted a strong Q4 2025 earnings print and followed it with a dividend hike, while the chart is in a confirmed uptrend (bullish MA stack and expanding positive MACD). Even though price is short-term extended/overbought and could pull back in the next 1–3 sessions, the combination of fresh earnings momentum, insider buying, and bullish options positioning makes it a good buy right now for an impatient buyer who doesn’t want to wait for a perfect dip.
Trend is bullish and strengthening: (1) Moving averages are stacked bullishly (SMA_5 > SMA_20 > SMA_200), confirming an established uptrend. (2) MACD histogram is positive (0.148) and expanding, signaling accelerating upside momentum. (3) RSI_6 at ~70.93 is near overbought—this often precedes a short pause or pullback rather than an immediate trend reversal. Levels: pivot ~76.89; prior resistance R1 ~79.62 has been cleared; R2 ~81.31 is effectively being tested/cleared with the post-market price ~81.77, implying a breakout but also a higher chance of near-term consolidation above 81. The pattern-based projection you provided also leans to a small next-day dip (60% chance to -1.34%), but a positive 1-month bias (+4.65%).
Earnings catalyst: Q4 2025 results were strong—record earnings reported and adjusted EPS of $1.78 (around expectations) alongside very strong year-over-year comparisons in the release headlines; net income reported at $96.2M.
Shareholder return: quarterly dividend increased to $0.67/share (board-approved; payable Feb 22, 2026), reinforcing confidence in cash generation/capital position.
Positioning/behavior: insiders are buying (buying amount up ~171.57% over the last month), which is a meaningful positive signal.
Technical breakout: price is pushing above the R2 zone (~81.31), which can attract momentum buyers.
Short-term overextension risk: RSI is near overbought and price is extended after a strong regular-session move (+4.42%) plus post-market follow-through, increasing odds of a near-term pullback/consolidation.
Analyst stance is not supportive at current price: the only provided rating is Neutral with a $74 target (below current ~81–82), which can cap near-term upside if others share that view.
Smart money trend: hedge funds are described as Neutral with no significant trend last quarter—no strong institutional tailwind indicated.
Statistical near-term bias: the provided candlestick-pattern analog suggests higher odds of a small next-day decline (-1.34%).
Latest quarter season in the news: Q4 2025 (reported 2026-01-30) was strong, highlighted by record earnings, net income of $96.2M, and adjusted EPS of $1.78. The provided financial snapshot (2025/Q3) also showed solid growth: revenue $84.885M (+14.28% YoY), net income $23.673M (+27.01% YoY), EPS $1.65 (+26.92% YoY). Overall, the growth trend across Q3 and the strong Q4 headline print supports an improving earnings trajectory into 2026, reinforced by the dividend increase.
Recent analyst activity provided: On 2025-12-03 Piper Sandler initiated coverage at Neutral with a $74 price target. Trend: only one recent data point here, but it’s effectively a cautious stance versus the current ~$81–82 price. Wall Street pros view (from what’s provided): Pros—regional bank coverage inclusion, business appears to be executing well as seen in recent earnings/dividend actions. Cons—target below market suggests limited upside in the near term unless fundamentals continue to surprise; Neutral implies ‘not compellingly undervalued’ at these levels.
